Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global 'One Health' Innovation
The current funding round will remain open for a further period to enable additional participation up to a further USD 10 million.
- The current funding round will remain open for a further period to enable additional participation up to a further USD 10 million.
- Eagle Genomics is the pre-eminent platform business using next-generation graph technology and network science to drive the Bioeconomy.
- The current scale-up funding will enable us to accelerate the Bioeconomy through the digital reinvention of science."
- Eagle Genomics is forging strategic relationships with leading scientific establishments focused on the microbiome and has helped shape the Microbiome Strategic Roadmap in the UK.